Biogen Inc. buy Needham & Company LLC
Start price
24.04.24
/
50%
€192.85
Target price
24.04.25
€275.07
Performance (%)
-45.97%
End price
25.04.25
€104.20
Summary
This prediction ended on 25.04.25 with a price of €104.20. Massive losses of -45.97% were the result for the BUY prediction by Needham___Company_LL. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -2.733% | -2.733% | 25.094% |
| iShares Core DAX® | 0,46 % | -2,00 % | 9,98 % |
| iShares Nasdaq 100 | -1,79 % | -5,74 % | -0,78 % |
| iShares Nikkei 225® | 5,12 % | 9,09 % | 28,82 % |
| iShares S&P 500 | -1,76 % | -3,67 % | -0,54 % |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $294.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten